Stay updated on Pembrolizumab in Neuroendocrine Tumors Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab in Neuroendocrine Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in Neuroendocrine Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    Revision tag updated from v3.6.5 to v3.6.6. This indicates a small backend/template update to the study details page and does not modify the displayed content.
    Difference
    0.1%
    Check dated 2026-08-29T20:04:28.000Z thumbnail image
  4. Check
    27 days ago
    No Change Detected
  5. Check
    41 days ago
    Change Detected
    Summary
    Revision: v3.6.5 was added, replacing the previous v3.6.4 on the page. This signals a minor platform update without changing the study's content or data presented.
    Difference
    0.1%
    Check dated 2026-08-08T20:13:14.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The page now shows an updated revision tag: v3.6.4, replacing the previous v3.6.3. This represents a small internal update and does not alter visible study information.
    Difference
    0.1%
    Check dated 2026-07-25T12:49:12.000Z thumbnail image
  7. Check
    77 days ago
    Change Detected
    Summary
    Updated the page revision from v3.6.2 to v3.6.3, a minor platform update that does not change the displayed study details.
    Difference
    0.1%
    Check dated 2026-07-03T23:23:57.000Z thumbnail image
  8. Check
    84 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.2, replacing the previous v3.6.0 label. This indicates a minor software update to the page's versioning without altering the study content.
    Difference
    0.1%
    Check dated 2026-06-26T20:00:00.000Z thumbnail image
  9. Check
    98 days ago
    Change Detected
    Summary
    New navigation/help sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and the recruitment status was updated to No longer looking for participants; the edition label updated to Revision: v3.6.0 and the Intervention/Treatment heading formatting was standardized.
    Difference
    0.5%
    Check dated 2026-06-12T13:29:49.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in Neuroendocrine Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in Neuroendocrine Tumors Clinical Trial page.